-
-
-
-
-
-
-
Enlivex secures $21 million debt financing and approves $20 million buyback
-
-
-
-
-
-
-
Pre-Open Stock Movers 10/01: (AEL) (AMAG) (BBBY) Higher; (ZSAN) (LOGC) (SPI) Lower (more...)
-
-
-
-
-
-
-
Immunotherapy Company Enlivex Therapeutics Announces Nasdaq Listing Under Symbol “ENLV” and Closing of Private Placement of Ordinary Shares Priced at $12.25 Per Share
1,167,027 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

